絞り込み

16645

広告

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

著者 Kudo M , Ueshima K , Ikeda M , Torimura T , Tanabe N , Aikata H , Izumi N , Yamasaki T , Nojiri S , Hino K , Tsumura H , Kuzuya T , Isoda N , Yasui K , Aino H , Ido A , Kawabe N , Nakao K , Wada Y , Yokosuka O , Yoshimura K , Okusaka T , Furuse J , Kokudo
Gut.2019 Dec 04 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (14view , 0users)

Full Text Sources

This trial compared the efficacy and safety of transarterial chemoembolisation (TACE) plus sorafenib with TACE alone using a newly established TACE-specific endpoint and pre-treatment of sorafenib before initial TACE.
PMID: 31801872 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード